Saudi Arabia SFDA registration ME0000003094SFDAA00051
LIAISON Rubella IgM
Saudi Arabia·Chemicals·DiaSorin S.p.A.·Annex II List BActiveProduct information
Kit for determination
of specific Immunoglobulin M antibodies to rubella virus
Product use
The LIAISON® Rubella IgM assay uses chemiluminescent immunoassay (CLIA) technology for the quantitative determination
of specific IgM antibodies to rubella virus in human serum or plasma samples.
The test has to be performed on the LIAISON® Analyzer.
Device classification
- Risk Class
- Annex II List B
- Product Category
- Chemicals
- Product Type
- IVD
Registration information
- Registration ID
- ME0000003094SFDAA00051
- Authorization ID
- MDMA-1-2019-4213
- Status
- Active
- Expire Date
- May 26, 2025
Manufacturer
- Manufacturer Name
- DiaSorin S.p.A.
Model information
- Model ID(s)
- 310730
Product accessories
[]
About this record
Access comprehensive regulatory information for LIAISON Rubella IgM in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List B device is registered with Saudi Arabia SFDA under registration number ME0000003094SFDAA00051 and manufactured by DiaSorin S.p.A..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official DataAnnex II List B